The 2026 AHA/ACC/ESC/WHF consensus redefines heart failure diagnosis, placing elevated cardiac filling pressure at the center of diagnostic criteria across all stages. The updated guidelines formally recognize non-invasive measurement of filling pressure as confirmatory evidence—even when biomarker levels are normal. By renaming Stage B to “pre-HF,” the consensus highlights a critical shift toward earlier detection within primary care settings.